Detection of MboII polymorphism at the 5′ promoter region of CYP3A4

被引：0
|
作者：
Cavalli, SA [1 ]
Hirata, MH [1 ]
Hirata, RDC [1 ]
机构：
[1] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508900 Sao Paulo, Brazil
来源：
CLINICAL CHEMISTRY | 2001年 / 47卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：348 / 351
页数：4
相关论文
共 50 条
  • [1] The effect of CYP3A4*1B 5′-promoter region polymorphism on cyclosporine pharmacokinetics among healthy volunteers.
    Min, DI
    Ellingrod, VL
    PHARMACOTHERAPY, 2002, 22 (10): : 1362 - 1362
  • [2] Lessons from the CYP3A4 promoter
    Schuetz, EG
    MOLECULAR PHARMACOLOGY, 2004, 65 (02) : 279 - 281
  • [3] CYP3A activity in African American and European American men:: Population differences and functional effect of the CYP3A4*1B 5′-promoter region polymorphism
    Wandel, C
    Witte, JS
    Hall, JM
    Stein, CM
    Wood, AJJ
    Wilkinson, GR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (01) : 82 - +
  • [4] Interindividual differences in hepatic expression of CYP3A4:: Relationship to genetic polymorphism in the 5′-upstream regulatory region
    Westlind, A
    Löfberg, L
    Tindberg, N
    Andersson, TB
    Ingelman-Sundberg, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 259 (01) : 201 - 205
  • [5] Pharmacogenomic effects of a polymorphism in the 5′ promotor region of CYP3A4 in stable kidney transplant recipients.
    Karlix, JL
    Walker, JR
    Myers, HA
    Johary, CF
    Faramie, WJ
    Reed, AI
    Silkensen, JR
    Van der Werf, WJ
    Hemming, AW
    Crabtree, JM
    Srinivas, TR
    Patton, PR
    Howard, RJ
    TRANSPLANTATION, 2000, 69 (08) : S220 - S220
  • [6] SEQUENCE OF THE 5'-FLANKING REGION OF CYP3A5 - COMPARATIVE-ANALYSIS WITH CYP3A4 AND CYP3A7
    JOUNAIDI, Y
    GUZELIAN, PS
    MAUREL, P
    VILAREM, MJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (03) : 1741 - 1747
  • [7] Association of the CYP3A4*1B 5′-flanking region polymorphism with cyclosporine pharmacokinetics in healthy subjects
    Min, DI
    Ellingrod, VL
    THERAPEUTIC DRUG MONITORING, 2003, 25 (03) : 305 - 309
  • [8] CYP3A4 and CYP3A5 genotyping by pyrosequencing
    Garsa, AA
    McLeod, HL
    Marsh, S
    BMC MEDICAL GENETICS, 2005, 6
  • [9] GLOBAL ANALYSIS OF CYP3A4 AND CYP3A5 GENOTYPE ON IN VIVO CLEARANCE OF CYP3A4 SUBSTRATES.
    Quinney, S. K.
    Schwartz, J. B.
    Hall, S. D.
    Gorski, J. C.
    Li, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S49 - S49
  • [10] Genetic polymorphism of CYP3A4 in childhood ALL.
    Maiorova, G
    Mogl, M
    Eckert, C
    Taube, T
    Schmid, H
    Proba, J
    Henze, G
    Seeger, K
    BLOOD, 2000, 96 (11) : 714A - 714A
12345